Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis

• Status: Completed
• Trial end date: 2005-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study will test the safety and efficacy of AAE581 in increasing Lumbar Spine bone mineral density (BMD) at 12 months, by Dexa-scan (DXA) in postmenopausal women with osteoporosis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis Pharmaceuticals

Criteria

Inclusion Criteria:

• BMD T Score between -2 to -3.5

• 50-75 years old

Exclusion Criteria:

• Urolithiasis

• Bisphosphonates

Other protocol-defined inclusion/exclusion criteria may apply.